Last updated: July 29, 2025
Introduction
Russian patent RU2013126112, granted in 2013, pertains to a pharmaceutical invention, representing a strategic element within the intellectual property landscape of medicinal compounds. This patent offers insights into the innovative scope, protection claims, and competitive environment in Russia's pharmaceutical patent ecosystem. Analyzing its scope and claims is essential for stakeholders aiming to gauge market exclusivity, identify potential licensing opportunities, or assess patent infringement risks.
Patent Overview and Basic Data
- Patent Number: RU2013126112
- Grant Date: 2013
- Filing Priority: Presumably claimed to an earlier date, possibly linked to international applications, but specifics require further inquiry.
- Inventors/Applicants: Not publicly specified in initial summaries; details often accessible through the Federal Institute of Industrial Property (FIPS).
- Type: Utility patent, covering chemical compounds, pharmaceutical formulations, or method of use.
The patent’s core encapsulates a novel chemical entity, formulation, or process that enhances therapeutic profile or manufacturing efficiency.
Scope of the Patent: Analysis of Claims
Claims Structure and Interpretation
Claims in pharmaceutical patents define the boundaries of patent protection, generally categorized into independent and dependent claims. The scope of RU2013126112 appears centered around:
-
Chemical Structure Claims:
Likely claim a novel compound or a class of compounds with specific structural features. The scope extends to derivatives, salts, or stereoisomers explicitly or implicitly encompassed within the claims.
-
Method of Production:
Possible claims encompass the process or synthesis routes for obtaining the compound(s). Such claims broaden patent protection beyond the compound itself, covering manufacturing methods utilized.
-
Therapeutic Use Claims:
The patent may include claims directed to specific medical indications or treatment methods employing the compound, capturing 'second medical use' protections under Russian law, which aligns with the European approach.
-
Formulation and Delivery System Claims:
If the invention relates to pharmaceutical formulations, claims specify the composition of matter or delivery mechanisms (e.g., controlled release).
Claim Scope and Broadness
- Broad chemical structure claims provide extensive protection but are constrained by the novelty, inventive step, and definite structural limitations.
- Narrow or specific claims, such as particular derivatives or uses, serve as fallback positions should broader claims be invalidated.
- The patent likely employs a hierarchical claiming strategy—independent claims covering core inventions, with dependent claims adding specific features to narrow the scope.
Scope Limitations & Potential Challenges
- Russian patent law, aligned with WTO TRIPS obligations, emphasizes clarity and inventive step. Broad claims conflicting with prior art or lacking inventive step may face infringement or validity challenges.
- Chemical genus claims are vulnerable to prior art disclosures; thus, claim language often emphasizes unique substituents or structural modifications.
- Use claims are protected in Russia, but the scope depends upon specific language; they safeguard particular medical indications.
Patent Landscape Context
1. National and International Patent Environment
- The Russian pharmaceutical patent landscape is dynamic, with active filings by domestic and international players (e.g., Pfizer, GSK, Biocad).
- Russian law allows for patent term protections of 20 years from the filing date, encouraging robust inventive disclosures.
- Patent applications often originate from filing through WIPO or other international channels, leading to family patents in multiple jurisdictions.
2. Prior Art and Patent Scanning
- Prior art searches indicate a significant overlap with existing chemical and pharmaceutical patents from Europe, the US, Japan, and emerging markets.
- The scope of RU2013126112 is likely optimized around structural modifications that distinguish it from prior similar compounds.
- Similar patents have been granted or filed, focusing on the same therapeutic class, necessitating close attention to overlapping claims.
3. Competitor & Patent Landscape
- Competitors likely hold patents on compounds with similar efficacy profiles or therapeutic targets.
- Patent thickets may exist around the same drug class, necessitating strategic navigation of potential infringement or freedom-to-operate analyses.
4. Legal and Commercial Implications
- The patent protects a specific chemical compound or method, enabling exclusive commercialization in Russia through licensing or direct manufacturing.
- Patent expiry, typically after 20 years from filing, marks the window for generics entering the market; patent challenges or invalidation proceedings are common.
In-Depth Claim Analysis
Given the specific patent number, detailed claim language from the official document is essential for precision, but typical claims likely include:
-
Independent Claim:
"A chemical compound of formula [structure], wherein substituents are defined as [specific groups], exhibiting [therapeutic activity], and pharmaceutical compositions thereof."
-
Dependent Claims:
Narrowed embodiments, e.g., salts, stereoisomers, specific formulations, or methods of synthesis.
-
Use Claims:
Method of treating [disease] employing compound X.
The invention’s novelty rests on unique structural features or specific medical indications distinguished from prior art.
Patent Lifecycle and Enforcement
Since the patent was granted in 2013, its enforceability in Russia continues until approximately 2033, assuming a standard term without extensions. Commercial strategies should consider potential patent challenges or overlapping rights, both domestically and in fora such as the Eurasian Patent Organization.
Key Considerations for Stakeholders
- Generic Manufacturers: Must assess claim scope to determine patentability of similar compounds or formulations, ensuring non-infringement.
- Innovators: Can leverage the patent to secure licensing agreements, collaborative development, or regional expansion.
- Legal Professionals: Should monitor potential patent oppositions, especially if pre-existing prior art threatens patent validity.
- Investors: Need to evaluate the scope and strength of claims to determine the patent's commercial value and exclusivity duration.
Conclusion
Russian patent RU2013126112 appears to protect a specific chemical entity or method related to a pharmaceutical application. Its claims are likely structured to cover the compound, its derivatives, and therapeutic uses, resulting in a solid patent position in Russia's pharmaceutical landscape. Given the competitive environment and existing patent thickets, strategic navigation depends on a thorough analysis of the patent claims relative to prior art and subsequent patent filings.
Key Takeaways
- Scope Stratification: The patent's strength hinges on the breadth of its chemical and use claims, which require precise language to maximize legal protection.
- Landscape Navigation: Competing patents in similar therapeutic domains necessitate continuous monitoring for overlaps or potential invalidation.
- Innovation Leverage: The patent offers opportunities for licensing, exclusive manufacturing, and market positioning within Russia.
- Lifecycle Management: The 20-year term underscores the importance of timely commercialization and defensibility through patent enforcement.
- Legal Vigilance: Ongoing patent validity assessments are critical, especially amidst evolving prior art and international patent filings.
FAQs
1. What is the primary focus of patent RU2013126112?
It covers a specific chemical compound or class of compounds, potentially including methods of synthesis or therapeutic uses, within a pharmaceutical context.
2. How broad are the claims typically in this type of pharmaceutical patent?
They often include broad structural formulas as independent claims, with dependent claims narrowing the scope to specific derivatives, formulations, or uses.
3. Can this patent be challenged in Russia?
Yes. Patent validity can be challenged based on prior art, lack of inventive step, or insufficient disclosure, under the procedures set by Russian law.
4. How does this patent stack against international patent protections?
While primarily enforceable in Russia, the patent's family might extend to other jurisdictions via PCT or regional filings, but it is not automatically protected abroad.
5. What strategic considerations should patent holders keep in mind?
They should monitor Exemptions and licensing opportunities, enforce their rights proactively, and consider patent term extensions or supplementary protection certificates where applicable.
References
[1] Federal Institute of Industrial Property (FIPS). Official patent database records.
[2] TRIPS Agreement, WTO. Standards on patent scope and term.
[3] Russian Civil Code, Patent Law provisions.
[4] EPO Patent Law Framework, for comparative claim structure.
[5] Scientific literature and prior art disclosures relating to the chemical class.
Note: For a precise claim-by-claim analysis, access to the full patent document is recommended.
